BidaskClub cut shares of Endo International (NASDAQ:ENDP) (TSE:ENL) from a sell rating to a strong sell rating in a research report released on Friday morning.
Several other equities research analysts have also issued reports on the stock. Mizuho lowered shares of Endo International from a buy rating to a neutral rating and dropped their price objective for the stock from $12.00 to $7.00 in a research report on Wednesday. ValuEngine lowered shares of Endo International from a hold rating to a sell rating in a research report on Monday, April 2nd. Barclays set a $9.00 price target on shares of Endo International and gave the company a hold rating in a report on Saturday, March 10th. BMO Capital Markets lowered their price target on shares of Endo International from $10.00 to $9.00 and set a market perform rating for the company in a report on Monday, March 5th. Finally, Gabelli lowered shares of Endo International from a buy rating to a hold rating in a report on Wednesday, February 28th. Four analysts have rated the stock with a sell rating, sixteen have issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of Hold and an average price target of $9.40.
Shares of Endo International stock traded down $0.23 during trading hours on Friday, hitting $5.49. The company’s stock had a trading volume of 4,200,166 shares, compared to its average volume of 5,113,560. Endo International has a 1-year low of $5.27 and a 1-year high of $14.15. The firm has a market capitalization of $1,277.51, a P/E ratio of 1.43 and a beta of 0.38. The company has a quick ratio of 0.85, a current ratio of 1.02 and a debt-to-equity ratio of 17.00.
A number of hedge funds and other institutional investors have recently bought and sold shares of ENDP. Cornerstone Capital Management Holdings LLC. boosted its stake in Endo International by 64.0% during the 3rd quarter. Cornerstone Capital Management Holdings LLC. now owns 135,627 shares of the company’s stock valued at $1,160,000 after acquiring an additional 52,927 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in Endo International during the 4th quarter valued at $236,000. Oakbrook Investments LLC bought a new position in Endo International during the 4th quarter valued at $133,000. Alps Advisors Inc. boosted its stake in Endo International by 22.9% during the 4th quarter. Alps Advisors Inc. now owns 307,839 shares of the company’s stock valued at $2,386,000 after acquiring an additional 57,328 shares during the last quarter. Finally, River & Mercantile Asset Management LLP boosted its stake in Endo International by 32.7% during the 4th quarter. River & Mercantile Asset Management LLP now owns 475,650 shares of the company’s stock valued at $3,679,000 after acquiring an additional 117,110 shares during the last quarter. Hedge funds and other institutional investors own 94.72% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3338365/endo-international-endp-downgraded-to-strong-sell-at-bidaskclub.html.
Endo International Company Profile
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.